SCHEMBL23029495

SCHEMBL23029495

CO[C@H]1C[C@@H](CNCC(C)C)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24842107 1.00 — —
SCHEMBL25769684 0.77 EPHX2 (0.34) —
SCHEMBL25769682 0.77 EPHX2 (0.34) —
SCHEMBL21618647 0.77 ANPEP (0.32) —
SCHEMBL23029496 0.77 ANPEP (0.32) —
SCHEMBL25994335 0.77 SAT1 (0.38) —
SCHEMBL24842354 0.77 EPHX2 (0.34) —
SCHEMBL24129485 0.77 SAT1 (0.38) —
SCHEMBL24842118 0.75 ANPEP (0.31) —
SCHEMBL22151776 0.75 HTR2C (0.34) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230212155-A1 PD-1/PD-L1 INHIBITORS GILEAD SCIENCES, INC. 2023-07-06 — — US disclosed
US-20230212155-A1 PD-1/PD-L1 INHIBITORS GILEAD SCIENCES, INC. 2023-07-06 — — US disclosed
US-20210053946-A1 PD-1/PD-L1 INHIBITORS GILEAD SCIENCES, INC. (US) 2021-02-25 — — US disclosed
Send feedback